Last reviewed · How we verify
Atopiclair Nonsteroidal Cream
At a glance
| Generic name | Atopiclair Nonsteroidal Cream |
|---|---|
| Also known as | MAS063DP |
| Sponsor | Wake Forest University Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Atopiclair Nonsteroidal Cream CI brief — competitive landscape report
- Atopiclair Nonsteroidal Cream updates RSS · CI watch RSS
- Wake Forest University Health Sciences portfolio CI